Calcitonin Gene-Related Peptide Enhances the Expression of Signaling Molecules of the Wnt 7b/Beta-Catenin Pathway in Rat Type II Alveolar Epithelial Cells Under Hyperoxia

Shao-Hua Wang, Yuan-Qing Chen, Long-Hui Li, Li Li, Hong-Xing Dang, Feng Xu

Abstract


Background: Hyperoxic lung injury is characterized by epithelial cell death and leukocyte infiltration/inflammation in the lung. Calcitonin gene-related peptide (CGRP) has been shown to improve survival of lung epithelial cells and reduce hyperoxic lung injury in rats. However, the mechanism of CGRP protective activity is not completely understood. The Wnt7b/β-catenin pathway plays an important role in lung development, repair and regeneration. This study therefore was designed to examine the regulatory role of CGRP in the Wnt7b/β-catenin pathway in type II alveolar epithelial cell (AEC II) under hyperoxia.

Methods: Rat neonates and AEC II from premature rats were exposed to hyperoxia in the absence or presence of CGRP, Wnt7b and β-catenin protein levels were measured by Western blot analysis, while T cell factor (TCF) and c-myc mRNA levels were determined by reverse transcription-polymerase chain reaction (RT-PCR).

Results: In the rat lung, both Wnt7b and β-catenin proteins were detectable, and hyperoxia significantly increased Wnt7b and β-catenin protein expression. AEC II, after exposure to hyperoxia, had significantly higher levels of Wnt7b and β-catenin proteins, and TCF and c-myc mRNAs, which was further enhanced by CGRP.

Conclusions: CGRP stimulates the expression of multiple molecules in the Wnt 7b/β-catenin pathway in AEC II under hyperoxia, which might be part of the mechanism by which CGRP protects the lung from hyperoxia-induced injury.




Cell Mol Med Res. 2017;1(1):15-19
doi: https://doi.org/10.14740/cmmr7e


Keywords


Calcitonin gene-related peptide; Type II alveolar epithelial cell; Oxidative stress; Lung injury; Wnt7b; β-catenin

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Cellular and Molecular Medicine Research, quarterly, ISSN 0000-0000 (print), 0000-0000 (online), published by Elmer Press Inc.     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thecmmr.org   editorial contact: editor@thecmmr.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

DECLARATION: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!